Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16893)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2016 (publication date) through Jun 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Golabi P, Locklear CT, Austin P, Afdhal S, Byrns M, Gerber L, Younossi ZM. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review. World J Gastroenterol 2016; 22(27): 6318-6327 [PMID: 27468220 DOI: 10.3748/wjg.v22.i27.6318] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i27/6318.htm |
| Number | Citing Articles |
| 1 |
Olivia McCarthy, Jason P. Pitt, Nicky Keay, Esben T. Vestergaard, Abbigail S. Y. Tan, Rachel Churm, Dafydd Aled Rees, Richard M. Bracken. Passing on the exercise baton: What can endocrine patients learn from elite athletes?. Clinical Endocrinology 2022; 96(6): 781 doi: 10.1111/cen.14683
|
| 2 |
Mariana de Sá Ramalho, Nathália Caroline de Oliveira Melo, Ana Patrícia Jaques Marquesa Quidut Araújo, Giselia de Santana Muniz, Elizabeth do Nascimento. Mild energy restriction and physical swimming activity: biochemical effects and food preference in male rats. Sport Sciences for Health 2019; 15(2): 319 doi: 10.1007/s11332-018-0515-5
|
| 3 |
Ling Ruan, Guanghua Wang, Zhen Qing Lv, Shoubang Li, Qin Liu, Yiling Ren, Quancheng Zhang, Xianli Lv, Rongping Wu, Zhan Ji. The effect of varied exercise intensity on antioxidant function, aortic endothelial function, and serum lipids in rats with non-alcoholic fatty liver disease.. Investigación Clínica 2022; 63(4): 327 doi: 10.54817/IC.v63n4a01
|
| 4 |
Ming Hong, Zhe Cai, Lei Song, Yongqiang Liu, Qi Wang, Xiangfei Feng, Kesara Na-Bangchang. Gynostemma pentaphyllum Attenuates the Progression of Nonalcoholic Fatty Liver Disease in Mice: A Biomedical Investigation Integrated with In Silico Assay. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/8384631
|
| 5 |
Mehmet Sayiner, Tamoore Arshad, Pegah Golabi, James Paik, Freba Farhat, Zobair M. Younossi. Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population. Hepatology International 2020; 14(4): 556 doi: 10.1007/s12072-020-10038-w
|
| 6 |
Ilias Vachliotis, Antonis Goulas, Paraskevi Papaioannidou, Stergios A. Polyzos. Nonalcoholic fatty liver disease: lifestyle and quality of life. Hormones 2022; 21(1): 41 doi: 10.1007/s42000-021-00339-6
|
| 7 |
Pegah Golabi, Mehmet Sayiner, Haley Bush, Lynn H. Gerber, Zobair M. Younossi. Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection. Clinics in Liver Disease 2017; 21(3): 565 doi: 10.1016/j.cld.2017.03.011
|
| 8 |
Elisa Barrón-Cabrera, Raúl Soria-Rodríguez, Fernando Amador-Lara, Erika Martínez-López. Physical Activity Protocols in Non-Alcoholic Fatty Liver Disease Management: A Systematic Review of Randomized Clinical Trials and Animal Models. Healthcare 2023; 11(14): 1992 doi: 10.3390/healthcare11141992
|
| 9 |
Homa Khaleghzadeh, Mohammad Esmaeil Afzalpour, Mohsen Mohammadnia Ahmadi, Mohsen Nematy, Mohammad Ali Sardar. Effect of high intensity interval training along with Oligopin supplementation on some inflammatory indices and liver enzymes in obese male Wistar rats with non-alcoholic fatty liver disease. Obesity Medicine 2020; 17: 100177 doi: 10.1016/j.obmed.2019.100177
|
| 10 |
Jonathan G. Stine, Michelle T. Long, Kathleen E. Corey, Robert E. Sallis, Alina M. Allen, Matthew J. Armstrong, David E. Conroy, Daniel J. Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J. Hickman, Matthew R. Kappus, Shelley E. Keating, Christopher J.A. Pugh, Yaron Rotman, Tracey G. Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H. Schmitz. American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology Communications 2023; 7(4) doi: 10.1097/HC9.0000000000000108
|
| 11 |
E. V. Kiseleva, T. Y. Demidova. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the problem of conjunction and phasing. Obesity and metabolism 2021; 18(3): 313 doi: 10.14341/omet12758
|
| 12 |
Jessica Spiers, James Hallimond Brindley, Wenhao Li, William Alazawi. What’s new in non-alcoholic fatty liver disease?. Frontline Gastroenterology 2022; 13(e1): e102 doi: 10.1136/flgastro-2022-102122
|
| 13 |
Yangjun Liu, Wei Xie, Juan Li, Zbigniew Ossowski. Effects of aerobic exercise on metabolic indicators and physical performance in adult NAFLD patients: A systematic review and network meta-analysis. Medicine 2023; 102(14): e33147 doi: 10.1097/MD.0000000000033147
|
| 14 |
I Sabinari, O Horakova, T Cajka, V Kleinova, MR Wieckowski, M Rossmeisl. Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD. Physiological Research 2024; (Suppl 1): S295 doi: 10.33549/physiolres.935396
|
| 15 |
Kathy Musa-Veloso, Carolina Venditti, Han Youl Lee, Maryse Darch, Seth Floyd, Spencer West, Ryan Simon. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease. Nutrition Reviews 2018; 76(8): 581 doi: 10.1093/nutrit/nuy022
|
| 16 |
Wenqi Yang, Ling Liu, Yuan Wei, Chunlu Fang, Shujing Liu, Fu Zhou, Yaping Li, Ge Zhao, Ziyi Guo, Yuan Luo, Liangming Li. Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin. Laboratory Investigation 2021; 101(3): 369 doi: 10.1038/s41374-020-00508-y
|
| 17 |
Kenneth Cusi, Scott Isaacs, Diana Barb, Rita Basu, Sonia Caprio, W. Timothy Garvey, Sangeeta Kashyap, Jeffrey I. Mechanick, Marialena Mouzaki, Karl Nadolsky, Mary E. Rinella, Miriam B. Vos, Zobair Younossi. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings. Endocrine Practice 2022; 28(5): 528 doi: 10.1016/j.eprac.2022.03.010
|
| 18 |
Christian von Loeffelholz, Sina M. Coldewey, Andreas L. Birkenfeld. A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies. Cells 2021; 10(7): 1822 doi: 10.3390/cells10071822
|
| 19 |
Aaron B. Koenig, Albert Tan, Hala Abdelaal, Fanny Monge, Zobair M. Younossi, Zachary D. Goodman. Review article: Hepatic steatosis and its associations with acute and chronic liver diseases. Alimentary Pharmacology & Therapeutics 2024; 60(2): 167 doi: 10.1111/apt.18059
|
| 20 |
Mathias Plauth, Lars Bechmann, Donata Grajecki, Felix Gundling, Ludwig Kramer, Andreas E. Kremer, Monika Rau, Andrea Schneider, Frank Tacke, Ingo van Thiel. S2k-Leitlinie Klinische Ernährung in der Hepatologie. Aktuelle Ernährungsmedizin 2024; 49(04): 256 doi: 10.1055/a-2338-1144
|
| 21 |
Robert Ross, Simrat Soni, Sarah Houle. Negative Energy Balance Induced by Exercise or Diet: Effects on Visceral Adipose Tissue and Liver Fat. Nutrients 2020; 12(4): 891 doi: 10.3390/nu12040891
|
| 22 |
Alessandro Mantovani, Andrea Dalbeni. Treatments for NAFLD: State of Art. International Journal of Molecular Sciences 2021; 22(5): 2350 doi: 10.3390/ijms22052350
|
| 23 |
Ethan C. Z. Lee, Vickram V. Anand, Alex C. Razavi, Pamela L. Alebna, Mark D. Muthiah, Mohammad S. Siddiqui, Nicholas W. S. Chew, Anurag Mehta. The Global Epidemic of Metabolic Fatty Liver Disease. Current Cardiology Reports 2024; 26(4): 199 doi: 10.1007/s11886-024-02025-6
|
| 24 |
Shaghayegh Khanmohammadi, Bruno Ramos-Molina, Mohammad Shafi Kuchay. NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptors. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2023; 17(7): 102788 doi: 10.1016/j.dsx.2023.102788
|
| 25 |
Rami Maaloul, Houssem Marzougui, Imen Ben Dhia, Sameh Ghroubi, Sémah Tagougui, Choumous Kallel, Tarak Driss, Mohamed Habib Elleuch, Fatma Ayadi, Mouna Turki, Omar Hammouda. Effectiveness of Ramadan diurnal intermittent fasting and concurrent training in the management of obesity: is the combination worth the weight?. Nutrition, Metabolism and Cardiovascular Diseases 2023; 33(3): 659 doi: 10.1016/j.numecd.2022.12.004
|
| 26 |
Grazia Pennisi, Gabriele Di Maria, Marco Enea, Marco Vaccaro, Ciro Celsa, Michela Antonucci, Giacinta Ciancimino, Carlo Ciccioli, Giuseppe Infantino, Claudia La Mantia, Adele Tulone, Vito Di Marco, Calogero Cammà, Salvatore Petta. A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta‐Analysis. Liver International 2025; 45(4) doi: 10.1111/liv.70056
|
| 27 |
Rômulo Pillon Barcelos, Luiz Fernando Freire Royes, Javier Gonzalez-Gallego, Guilherme Bresciani. Oxidative stress and inflammation: liver responses and adaptations to acute and regular exercise. Free Radical Research 2017; 51(2): 222 doi: 10.1080/10715762.2017.1291942
|
| 28 |
Gerald Klaassen, Eva Corpeleijn, Nicole P.E. Deetman, Gerjan J. Navis, Stephan J.L. Bakker, Dorien M. Zelle. Liver Enzymes and the Development of Posttransplantation Diabetes Mellitus in Renal Transplant Recipients. Transplantation Direct 2017; 3(9): e208 doi: 10.1097/TXD.0000000000000717
|
| 29 |
K. A. Andreev, Yu. P. Skirdenko, N. A. Nikolaev, M. A. Livzan, A. V. Gorbenko, M. M. Fedorin, T. S. Krolevets. Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease. Bulletin of Siberian Medicine 2022; 20(4): 112 doi: 10.20538/1682-0363-2021-4-112-122
|
| 30 |
Ferya ÇELİK, Merve YÜKSEL, Hicran BEKTAŞ. Sessiz Epidemi: Metabolik Disfonksiyon İlişkili Karaciğer Yağlanması Hastalığının Önlenmesine ve Yönetilmesine Yönelik Güncel Yaklaşımlar. Artuklu International Journal of Health Sciences 2023; 3(3): 343 doi: 10.58252/artukluder.1359823
|
| 31 |
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólico. Revista de Gastroenterología de México 2019; 84(1): 69 doi: 10.1016/j.rgmx.2018.11.007
|
| 32 |
Alan Rodríguez-Carrillo, Mario Espinoza-Vargas, Katya Vargas-Ortiz, Lorena Ibarra-Reynoso, Monserrat Olvera-Juárez, Armando Gómez-Ojeda, Ma. Garay-Sevilla, Arturo Figueroa. Impact of L-Citrulline Supplementation and HIIT on Lipid Profile, Arterial Stiffness, and Fat Mass in Obese Adolescents with Metabolic-Dysfunction-Associated Fatty Liver Disease: A Randomized Clinical Trial. Nutrients 2025; 17(3): 402 doi: 10.3390/nu17030402
|
| 33 |
Irineu O. M. Callegari, Guilherme Z. Rocha, Alexandre G. Oliveira. Physical exercise, health, and disease treatment: The role of macrophages. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1061353
|
| 34 |
Joonpyo Lee, Mi-Seung Shin. Nonalcoholic fatty liver disease and heart failure with preserved ejection fraction: a focus on risk factors and management. Cardiovascular Prevention and Pharmacotherapy 2025; 7(1): 1 doi: 10.36011/cpp.2025.7.e2
|
| 35 |
Francesca Battista, Andrea Ermolao, Marleen A. van Baak, Kristine Beaulieu, John E. Blundell, Luca Busetto, Eliana V. Carraça, Jorge Encantado, Dror Dicker, Nathalie Farpour‐Lambert, Adriyan Pramono, Alice Bellicha, Jean‐Michel Oppert. Effect of exercise on cardiometabolic health of adults with overweight or obesity: Focus on blood pressure, insulin resistance, and intrahepatic fat—A systematic review and meta‐analysis. Obesity Reviews 2021; 22(S4) doi: 10.1111/obr.13269
|
| 36 |
Ambrin Farizah Babu, Susanne Csader, Ville Männistö, Milla-Maria Tauriainen, Heikki Pentikäinen, Kai Savonen, Anton Klåvus, Ville Koistinen, Kati Hanhineva, Ursula Schwab. Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-10481-9
|
| 37 |
F Qi, T Li, Q Deng, A Fan. The Impact of Aerobic and Anaerobic Exercise Interventions on the Management and Outcomes of Non-Alcoholic Fatty Liver Disease. Physiological Research 2024; (5/2024): 671 doi: 10.33549/physiolres.935244
|
| 38 |
Yuou Ying, Yuan Ji, Ruyi Ju, Jinhan Chen, Mingxian Chen. Association between the triglyceride-glucose index and liver fibrosis in adults with metabolism-related fatty liver disease in the United States: a cross-sectional study of NHANES 2017–2020. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-024-03579-z
|
| 39 |
Maria Lastra Cagigas, Isabella De Ciutiis, Andrius Masedunskas, Luigi Fontana. Dietary and pharmacological energy restriction and exercise for healthspan extension. Trends in Endocrinology & Metabolism 2025; 36(6): 521 doi: 10.1016/j.tem.2025.04.001
|
| 40 |
Wayne Eskridge, Donna R. Cryer, Jörn M. Schattenberg, Amalia Gastaldelli, Harmeet Malhi, Alina M. Allen, Mazen Noureddin, Arun J. Sanyal. Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective. Journal of Clinical Medicine 2023; 12(19): 6216 doi: 10.3390/jcm12196216
|
| 41 |
Hong Jun Yang, Yeon Pyo Hong, Tai-Young Yoon, Jae-Hong Ryoo, Joong-Myung Choi, Chang-Mo Oh. Independent and Synergistic Associations of Aerobic Physical Activity and Resistance Exercise with Nonalcoholic Fatty Liver Disease. Gut and Liver 2023; 17(4): 600 doi: 10.5009/gnl220345
|
| 42 |
Kevan Josloff, Jacob Beiriger, Adnan Khan, Richard J. Gawel, Richard S. Kirby, Aaron D. Kendrick, Abhinav K. Rao, Roy X. Wang, Michelle M. Schafer, Margaret E. Pearce, Kashyap Chauhan, Yash B. Shah, Gregary D. Marhefka, Dina Halegoua-DeMarzio. Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease. Journal of Cardiovascular Development and Disease 2022; 9(12): 419 doi: 10.3390/jcdd9120419
|
| 43 |
Manu V. Chakravarthy, Thomas Waddell, Rajarshi Banerjee, Nicola Guess. Nutrition and Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2020; 49(1): 63 doi: 10.1016/j.gtc.2019.09.003
|
| 44 |
Kim Edmunds, Haitham Tuffaha, Paul Scuffham, Daniel A Galvão, Robert U Newton. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review. Supportive Care in Cancer 2020; 28(12): 5661 doi: 10.1007/s00520-020-05637-0
|
| 45 |
Mohammed Eslam, Shiv K. Sarin, Vincent Wai-Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming-Hua Zheng, Gamal Shiha, Yusuf Yilmaz, Rino Gani, Shahinul Alam, Yock Young Dan, Jia-Horng Kao, Saeed Hamid, Ian Homer Cua, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata, Jacob George. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International 2020; 14(6): 889 doi: 10.1007/s12072-020-10094-2
|
| 46 |
Zobair M. Younossi, Shira Zelber-Sagi, Linda Henry, Lynn H. Gerber. Lifestyle interventions in nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology 2023; 20(11): 708 doi: 10.1038/s41575-023-00800-4
|
| 47 |
Amrita Kandel, Poonam Pant, Sushila Todi, Sudhamshu KC, Sudip Pandey. Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease. SAGE Open Medicine 2024; 12 doi: 10.1177/20503121241227090
|
| 48 |
Rosario Martínez, Garyfallia Kapravelou, Ana Donaire, Carlos Lopez-Chaves, Francisco Arrebola, Milagros Galisteo, Samuel Cantarero, Pilar Aranda, Jesus M. Porres, María López-Jurado. Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats. Food & Function 2018; 9(2): 830 doi: 10.1039/C7FO01790A
|
| 49 |
Dirk J. van der Windt, Vikas Sud, Hongji Zhang, Allan Tsung, Hai Huang. The Effects of Physical Exercise on Fatty Liver Disease. Gene Expression 2018; 18(2): 89 doi: 10.3727/105221617X15124844266408
|
| 50 |
Luc F. Van Gaal, Jonathan Mertens, Sven Francque, Christophe De Block. Therapeutic approaches for non-alcoholic steatohepatitis. Therapeutic Advances in Endocrinology and Metabolism 2021; 12 doi: 10.1177/20420188211034300
|
| 51 |
J. A. Sargeant, L. J. Gray, D. H. Bodicoat, S. A. Willis, D. J. Stensel, M. A. Nimmo, G. P. Aithal, J. A. King. The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta‐analysis. Obesity Reviews 2018; 19(10): 1446 doi: 10.1111/obr.12719
|
| 52 |
Chun-Yi Wang, Hsiang-Han Kao, Kuan-Yu Lai, Ching-Chun Lin, Wen-Yuan Lin, Chiu-Shong Liu, Tsung-Po Chen. Clinical and Metabolic Characteristics of Hyperuricemia with Risk of Liver Fibrosis: A Cross-Sectional Study. Metabolites 2022; 12(10): 893 doi: 10.3390/metabo12100893
|
| 53 |
Mathias Plauth. Comprehensive Guide to Hepatitis Advances. 2023; : 87 doi: 10.1016/B978-0-323-98368-6.00004-5
|
| 54 |
Margaret Spinosa, She-Yan Wong. Screening for Non-alcoholic Fatty Liver Disease in Current Practice. Current Hepatology Reports 2021; 20(4): 128 doi: 10.1007/s11901-021-00577-7
|
| 55 |
Rong Xu, Difei Lian, Yan Xie, Zhilei Chen, Yan Wang, Lin Mu, Yuan Wang, Baoyu Zhang. SGLT-2 Inhibitors for Non-Alcoholic Fatty Liver Disease: A Review. Frontiers in Bioscience-Landmark 2023; 28(7) doi: 10.31083/j.fbl2807134
|
| 56 |
Lynn H Gerber, Ali A Weinstein, Rohini Mehta, Zobair M Younossi. Importance of fatigue and its measurement in chronic liver disease. World Journal of Gastroenterology 2019; 25(28): 3669-3683 doi: 10.3748/wjg.v25.i28.3669
|
| 57 |
E. Roeb, A. Canbay, H. Bantel, J. Bojunga, J. de Laffolie, M. Demir, U. W. Denzer, A. Geier, W. P. Hofmann, C. Hudert, T. Karlas, M. Krawczyk, T. Longerich, T. Luedde, M. Roden, J. Schattenberg, M. Sterneck, A. Tannapfel, P. Lorenz, F. Tacke. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09): 1346 doi: 10.1055/a-1880-2283
|
| 58 |
Jieyi Wang, Jinhan Chen, Mingxian Chen. Commentary: Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.1056394
|
| 59 |
Omer Shahab, Rakesh Biswas, James Paik, Haley Bush, Pegah Golabi, Zobair M. Younossi. Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality. Hepatology Communications 2018; 2(10): 1227 doi: 10.1002/hep4.1241
|
| 60 |
Simona Cernea, Danusia Onișor. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(2): 286-309 doi: 10.3748/wjg.v29.i2.286
|
| 61 |
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
|
| 62 |
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09): e733 doi: 10.1055/a-1880-2388
|
| 63 |
Niharika Samala, Sarah A. Tersey, Naga Chalasani, Ryan M. Anderson, Raghavendra G. Mirmira. Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase. Journal of Diabetes and its Complications 2017; 31(11): 1630 doi: 10.1016/j.jdiacomp.2017.07.014
|
| 64 |
Peter Deibert, Adhara Lazaro, Denise Schaffner, Aloys Berg, Daniel Koenig, Wolfgang Kreisel, Manfred W Baumstark, Daniel Steinmann, Martin Buechert, Thomas Lange. Comprehensive lifestyle intervention <i>vs</i> soy protein-based meal regimen in non-alcoholic steatohepatitis. World Journal of Gastroenterology 2019; 25(9): 1116-1131 doi: 10.3748/wjg.v25.i9.1116
|
| 65 |
Dawei GUO, Jian SUN, Shuolei FENG. Comparative analysis of the effects of high-intensity interval training and traditional aerobic training on improving physical fitness and biochemical indicators in patients with non-alcoholic fatty liver disease. The Journal of Sports Medicine and Physical Fitness 2024; 65(1) doi: 10.23736/S0022-4707.24.16206-8
|
| 66 |
Shelley E. Keating, Angelo Sabag, Kate Hallsworth, Ingrid J. Hickman, Graeme A. Macdonald, Jonathan G. Stine, Jacob George, Nathan A. Johnson. Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia. Sports Medicine 2023; 53(12): 2347 doi: 10.1007/s40279-023-01918-w
|
| 67 |
Shanshan Guo, Yiru Huang, Yan Zhang, He Huang, Shangyu Hong, Tiemin Liu. Impacts of exercise interventions on different diseases and organ functions in mice. Journal of Sport and Health Science 2020; 9(1): 53 doi: 10.1016/j.jshs.2019.07.004
|
| 68 |
Xiaoli Qian, Ting Wang, Jiahong Gong, Li Wang, Xuyan Chen, Haiyan Lin, Wenzhan Tu, Songhe Jiang, Shengcun Li. Exercise in mice ameliorates high-fat diet-induced nonalcoholic fatty liver disease by lowering HMGCS2. Aging 2021; 13(6): 8960 doi: 10.18632/aging.202717
|
| 69 |
Zobair M. Younossi, Maria Stepanova, Rebecca A. Taub, Jordan Mark Barbone, Stephen A. Harrison. Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life. Clinical Gastroenterology and Hepatology 2022; 20(6): 1354 doi: 10.1016/j.cgh.2021.07.039
|
| 70 |
Joyal Xavier, Sanjiv Singh, Priyanka Kumari, V. Ravichandiran. Neurological repercussions of neonatal nicotine exposure: A review. International Journal of Developmental Neuroscience 2022; 82(1): 3 doi: 10.1002/jdn.10163
|
| 71 |
Fatiha Nassir, Jamal A Ibdah. Sirtuins and nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(46): 10084-10092 doi: 10.3748/wjg.v22.i46.10084
|
| 72 |
Chenjing Li, Yihua Feng, Jingyao Li, Rui Lian, Liehao Qin, Chunling Wang. Extraction, purification, structural characterization, and hepatoprotective effect of the polysaccharide from purple sweet potato. Journal of the Science of Food and Agriculture 2023; 103(4): 2196 doi: 10.1002/jsfa.12239
|
| 73 |
Maria Guarino, Pavitra Kumar, Andrea Felser, Luigi M. Terracciano, Sergi Guixé-Muntet, Bostjan Humar, Michelangelo Foti, Jean-Marc Nuoffer, Marie V. St-Pierre, Jean-François Dufour. Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice. Cancers 2020; 12(6): 1407 doi: 10.3390/cancers12061407
|
| 74 |
Kahei Au, Ming-Hua Zheng, Wei-Jei Lee, Omar M. Ghanem, Kamal Mahawar, Asim Shabbir, Carel W. le Roux, Giovanni Targher, Christopher D. Byrne, Yusuf Yilmaz, Luca Valenti, Giada Sebastiani, Sombat Treeprasertsuk, Hannah Xiaoyan Hui, Nasser Sakran, Manoel Galvao Neto, Mohammad Kermansaravi, Lilian Kow, Yosuke Seki, Kwang Wei Tham, Jerry Dang, Ricardo V. Cohen, Christine Stier, Salman AlSabah, Rodolfo J. Oviedo, Sonja Chiappetta, Chetan Parmar, Wah Yang, Kahei Au, Ming-Hua Zheng, Wei-Jei Lee, Omar M Ghanem, Kamal Mahawar, Asim Shabbir, Carel W le Roux, Giovanni Targher, Christopher D. Byrne, Yusuf Yilmaz, Luca Valenti, Giada Sebastiani, Sombat Treeprasertsuk, Hannah Xiaoyan Hui, Nasser Sakran, Manoel Galvao Neto, Mohammad Kermansaravi, Lilian Kow, Yosuke Seki, Kwang Wei Tham, Jerry Dang, Ricardo V Cohen, Christine Stier, Salman AlSabah, Rodolfo J Oviedo, Sonja Chiappetta, Chetan Parmar, Wah Yang, Tamer Nabil Abdelbaki, Mohamed Abouelazayem, Adel Karim Abou-Mrad, Adam Abu-Abeid, Suhaib Ahmad, Hazem Al-Momani, Bassem Amr, Rahmatullah athar, Selmy S Awad, Muhammed Rasid Aykota, Ali Haider Bangash, Ruth Blackham, Ismail Calikoglu, Patricia Yoshimia Castillo Vacaflor, Suleyman Cetinkunar, Jin Chai, Tao Chen, An-Tian Chen, Andre Costa-Pinho, Anna Carolina Batista Dantas, Nadia De Falco, Viorel Dejeu, Tugrul Demirel, Yi Duan, Mohamad Hayssam Elfawal, Hosam M Elghadban, Mostafa Refaie Elkeleny, Yu-Chen Fan, Tingyu Fang, Daniel Moritz Felsenreich, Jose Eduardo Garcia Flores, Khaled Aly Gawdat, Omar Ghazouani, Li Hai, Juqiang Han, Yingli Hee, Anna Carolina Hoff, Songhao Hu, Ang Huang, Sara Ingallinella, Richa Jaiswal, Fanpu Ji, Abd-Elfattah Morsi Kalmoush, Nik Ritza Kosai, Panagiotis Lainas, Muffazal Lakdawala, Yaming Liu, Skye Marshall, Pedro R Martinez-Duartez, Marco Materazzo, Giovanni Merola, Karl Anton Miller, Aleksandr Neimark, Stephen Ka-kei Ng, Abdulellah Mohamedamin Niyaz, Taryel Isgender Omarov, Mariano Palermo, Guillermo Ponce de Leon-Ballesteros, Dimitri J Pournaras, Sjaak Pouwels, Xingshun Qi, Reynaldo Martins e Quinino, Ravi Rao, Vittal Sree Rama Rao, Karl Peter Rheinwalt, Felipe Martin Bianco Rossi, Jaime Ruiz-Tovar, Elena Ruiz-Ucar, Sukhvinder Singh Saggu, Elgun Samadov, Cosimo Saviello, Romano Schneider, Roman Schumann, Sarah Seyedyousefi, Shahab Shahabi Shahmiri, Yongpeng Shi, Rob Snoekx, Xavier Sousa, Dan-Qin Sun, Kon Voi Tay, Salvatore Tolone, Zaher Toumi, Suthep Udomsawaengsup, Ala Wafa, Ningjian Wang, Ke Wang, Zhuoqi Wei, Thejana Kamil Wijeratne, Mingfeng Xia, Pengfei Xu, Liang Xu, Baowen Yuan, Roxanna Zakeri, Carlos Zerrweck, Jinshan Zhang, Wen Zhang, Le Zhang, Xiao-Dong Zhou, Mauricio Zuluaga Zuluaga. Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals. Current Obesity Reports 2024; 13(4): 818 doi: 10.1007/s13679-024-00582-z
|
| 75 |
Nagat Younan, Samah Elattar, Mira Farouk, Laila Rashed, Suzanne Estaphan. Dipeptidyl peptidase‐4 inhibitors and aerobic exercise synergistically protect against liver injury in ovariectomized rats. Physiological Reports 2019; 7(17) doi: 10.14814/phy2.14191
|
| 76 |
飏 屈. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Clinical Evidence and a Mechanistic Review. Advances in Clinical Medicine 2023; 13(08): 12753 doi: 10.12677/ACM.2023.1381788
|
| 77 |
Nimantha M.W. de Alwis. Practical Guide to Obesity Medicine. 2018; : 89 doi: 10.1016/B978-0-323-48559-3.00009-9
|
| 78 |
Rebecca Sewter, Susan Heaney, Amanda Patterson. Coffee Consumption and the Progression of NAFLD: A Systematic Review. Nutrients 2021; 13(7): 2381 doi: 10.3390/nu13072381
|
| 79 |
Chaheyla R St Aubin, Amy L Fisher, Jose A Hernandez, Tom L Broderick, Layla Al-Nakkash. Mitigation of MAFLD in High Fat-High Sucrose-Fructose Fed Mice by a Combination of Genistein Consumption and Exercise Training. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 2157 doi: 10.2147/DMSO.S358256
|
| 80 |
Lais S Garcêz, Camila R Avelar, Nedja S S Fonseca, Priscila R F Costa, André C Lyra, Carla M Cunha, Rosangela P Jesus, Lucivalda P M Oliveira. Effect of dietary carbohydrate and lipid modification on clinical and anthropometric parameters in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutrition Reviews 2021; 79(12): 1321 doi: 10.1093/nutrit/nuaa146
|
| 81 |
Ali A. Weinstein, Dung Ngo, Leyla de Avila, Jillian K. Price, Pegah Golabi, Patrick Austin, Carey Escheik, Lynn H. Gerber, Zobair M. Younossi. Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease. Annals of Medicine 2023; 55(1): 1345 doi: 10.1080/07853890.2023.2193422
|
| 82 |
Andrew D. Schreiner, Naveed Sattar. Identifying Patients with Nonalcoholic Fatty Liver Disease in Primary Care: How and for What Benefit?. Journal of Clinical Medicine 2023; 12(12): 4001 doi: 10.3390/jcm12124001
|
| 83 |
Dominic J. Chartrand, Eric Larose, Paul Poirier, Patrick Mathieu, Natalie Alméras, Philippe Pibarot, Benoît Lamarche, Caroline Rhéaume, Jean-Pierre Després. Visceral adiposity and liver fat as mediators of the association between cardiorespiratory fitness and plasma glucose-insulin homeostasis. American Journal of Physiology-Endocrinology and Metabolism 2020; 319(3): E548 doi: 10.1152/ajpendo.00251.2020
|
| 84 |
Sulin Cheng, Jun Ge, Can Zhao, Shenglong Le, Yifan Yang, Dandan Ke, Na Wu, Xiao Tan, Xiaobo Zhang, Xiaming Du, Jianqin Sun, Renwei Wang, Yongyong Shi, Ronald J. H. Borra, Riitta Parkkola, Petri Wiklund, Dajiang Lu. Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-16159-x
|
| 85 |
Hong-Tai Chang, Hsiang-Ju Pan, Chien-Hung Lee. Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients. Clinical Breast Cancer 2018; 18(4): e677 doi: 10.1016/j.clbc.2017.11.010
|
| 86 |
Anna Radziejewska, Agata Muzsik, Fermín I. Milagro, J. Alfredo Martínez, Agata Chmurzynska. One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. Lifestyle Genomics 2020; 13(2): 53 doi: 10.1159/000504602
|
| 87 |
Akshay Shetty, Fanny Giron, Mukul K. Divatia, Muhammad I. Ahmad, Sudha Kodali, David Victor. Nonalcoholic Fatty Liver Disease after Liver Transplant. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00072
|
| 88 |
Georg Semmler, Christian Datz, Thomas Reiberger, Michael Trauner. Diet and exercise in NAFLD/NASH: Beyond the obvious. Liver International 2021; 41(10): 2249 doi: 10.1111/liv.15024
|
| 89 |
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar. Letter: non‐invasive prediction models to exclude cirrhosis in NAFLD – not everyone fits the mould. Alimentary Pharmacology & Therapeutics 2022; 56(1): 180 doi: 10.1111/apt.16931
|
| 90 |
Georgios Tsamos, Dimitra Vasdeki, Theocharis Koufakis, Vassiliki Michou, Kali Makedou, Georgios Tzimagiorgis. Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes. Metabolites 2023; 13(4): 517 doi: 10.3390/metabo13040517
|
| 91 |
Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran. Non-alcoholic Fatty Liver Disease: A Clinical Update. Journal of Clinical and Translational Hepatology 2017; (XX): XX doi: 10.14218/JCTH.2017.00013
|
| 92 |
Stan Driessen, Vivian D. de Jong, Koen C. van Son, Tatiana Klompenhouwer, Yann Colardelle, Marco Alings, Cristophe Moreno, Stefan D. Anker, Manuel Castro Cabezas, Adriaan G. Holleboom, Diederick E. Grobbee, Maarten E. Tushuizen. A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey. United European Gastroenterology Journal 2023; 11(7): 654 doi: 10.1002/ueg2.12445
|
| 93 |
Tom Cormier. Exercise Programming for Nonalcoholic Fatty Liver Disease. Strength & Conditioning Journal 2019; 41(4): 89 doi: 10.1519/SSC.0000000000000462
|
| 94 |
Pegah Golabi, Haley Bush, Zobair M. Younossi. Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2017; 21(4): 739 doi: 10.1016/j.cld.2017.06.010
|
| 95 |
Lixiang Fu, Wenyue Zhang, Yupei Ao, Zhongling Zheng, Huaidong Hu. Efficacy of aerobic and resistance exercises in improving visceral adipose in patients with non-alcoholic fatty liver: a meta-analysis of randomized controlled trials. Zeitschrift für Gastroenterologie 2022; 60(11): 1644 doi: 10.1055/a-1742-4257
|
| 96 |
Nahum Méndez-Sánchez, Shreya C. Pal, Jacqueline Córdova-Gallardo. How far are we from an approved drug for nonalcoholic steatohepatitis?. Expert Opinion on Pharmacotherapy 2023; 24(9): 1021 doi: 10.1080/14656566.2023.2206953
|
| 97 |
Oh Young Kwon, Mi Kyung Lee, Hye Won Lee, Hyerang Kim, Jae Seung Lee, Yeonsoo Jang. Mobile App–Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial. Journal of Medical Internet Research 2024; 26: e49839 doi: 10.2196/49839
|
| 98 |
Maurizio Bonacini, Farah Kassamali, Swathi Kari, Nieves Lopez Barrera, Mohamed Kohla. Racial differences in prevalence and severity of non-alcoholic fatty liver disease. World Journal of Hepatology 2021; 13(7): 763-773 doi: 10.4254/wjh.v13.i7.763
|
| 99 |
Austin Henry, James M. Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, Lynn Gerber, Zobair M. Younossi. Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). Alimentary Pharmacology & Therapeutics 2023; 57(6): 709 doi: 10.1111/apt.17308
|
| 100 |
Julia Otten, Andreas Stomby, Maria Waling, Andreas Isaksson, Ingegerd Söderström, Mats Ryberg, Michael Svensson, Jón Hauksson, Tommy Olsson. A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial. Diabetologia 2018; 61(7): 1548 doi: 10.1007/s00125-018-4618-y
|
| 101 |
Shiv Chitturi, Vincent Wai‐Sun Wong, Wah‐Kheong Chan, Grace Lai‐Hung Wong, Simon Kin‐Hung Wong, Jose Sollano, Yen‐Hsuan Ni, Chun‐Jen Liu, Yu‐Cheng Lin, Laurentius Adrianto Lesmana, Seung Up Kim, Etsuko Hashimoto, Masahide Hamaguchi, Khean‐Lee Goh, Jiangao Fan, Ajay Duseja, Yock Young Dan, Yogesh Chawla, Geoff Farrell, Henry Lik‐Yuen Chan. The Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups. Journal of Gastroenterology and Hepatology 2018; 33(1): 86 doi: 10.1111/jgh.13856
|
| 102 |
Fatiha Nassir. NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules 2022; 12(6): 824 doi: 10.3390/biom12060824
|
| 103 |
Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, Rafał Filip, Alessandro Granito. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/4344905
|
| 104 |
Daniel Pfirrmann, Yvonne Huber, Jörn Markus Schattenberg, Perikles Simon. Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study. Journal of Medical Internet Research 2019; 21(1): e11250 doi: 10.2196/11250
|
| 105 |
Ambrin Farizah Babu, Susanne Csader, Johnson Lok, Carlos Gómez-Gallego, Kati Hanhineva, Hani El-Nezami, Ursula Schwab. Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis. Nutrients 2021; 13(9): 3135 doi: 10.3390/nu13093135
|
| 106 |
V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 104 doi: 10.22416/1382-4376-2022-32-4-104-140
|
| 107 |
Yuqiao Liu, Yue Fan, Jibin Liu, Xiyang Liu, Xiuyan Li, Jingqing Hu. Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1499602
|
| 108 |
Pegah Golabi, James Paik, Rashmi Reddy, Elisabetta Bugianesi, Gregory Trimble, Zobair M. Younossi. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0972-6
|
| 109 |
Yaqi Xue, Yang Peng, Litian Zhang, Yi Ba, Gang Jin, Ge Liu. Effect of different exercise modalities on nonalcoholic fatty liver disease: a systematic review and network meta-analysis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-51470-4
|
| 110 |
Patrick Austin, Lynn Gerber, James M. Paik, Jillian K. Price, Carey Escheik, Zobair M. Younossi. Aerobic capacity and exercise performance in nonalcoholic fatty liver disease. The Journal of Sports Medicine and Physical Fitness 2019; 59(8) doi: 10.23736/S0022-4707.19.09231-4
|
| 111 |
Hyo-In Choi, Mi Yeon Lee, Hyunah Kim, Byeong Kil Oh, Seung Jae Lee, Jeong Gyu Kang, Sung Ho Lee, Byung Jin Kim, Bum Soo Kim, Jin Ho Kang, Jong-Young Lee, Ki-Chul Sung. Effect of physical activity on the development and the resolution of nonalcoholic fatty liver in relation to body mass index. BMC Public Health 2022; 22(1) doi: 10.1186/s12889-022-13128-6
|
| 112 |
Jian-Gao Fan, Seung-Up Kim, Vincent Wai-Sun Wong. New trends on obesity and NAFLD in Asia. Journal of Hepatology 2017; 67(4): 862 doi: 10.1016/j.jhep.2017.06.003
|
| 113 |
Jun Li, Simin Hua, Guo‐Chong Chen, Garrett Strizich, Mark H. Kuniholm, Zhilei Shan, Gregory A. Talavera, Sheila F. Castañeda, Marc D. Gellman, Jianwen Cai, Scott J. Cotler, Xuehong Zhang, Frank B. Hu, Robert Kaplan, Carmen R. Isasi, Qibin Qi. Objectively measured sedentary time, physical activity and liver enzyme elevations in US Hispanics/Latinos. Liver International 2020; 40(8): 1883 doi: 10.1111/liv.14514
|
| 114 |
Zobair M. Younossi, Kathleen E. Corey, Joseph K. Lim. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology 2021; 160(3): 912 doi: 10.1053/j.gastro.2020.11.051
|
| 115 |
Anja Bosy-Westphal, Wiebke Braun, Viktoria Albrecht, Manfred J. Müller. Determinants of ectopic liver fat in metabolic disease. European Journal of Clinical Nutrition 2019; 73(2): 209 doi: 10.1038/s41430-018-0323-7
|
| 116 |
Mariana Verdelho Machado. Aerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 3627 doi: 10.2147/DMSO.S304357
|
| 117 |
Haoxuan Zou, Jiejie Xie, Xiaopu Ma, Yan Xie, Xingshun Qi. The Value of TyG‐Related Indices in Evaluating MASLD and Significant Liver Fibrosis in MASLD. Canadian Journal of Gastroenterology and Hepatology 2025; 2025(1) doi: 10.1155/cjgh/5871321
|
| 118 |
JONATHAN G. STINE, MICHELLE T. LONG, KATHLEEN E. COREY, ROBERT E. SALLIS, ALINA M. ALLEN, MATTHEW J. ARMSTRONG, DAVID E. CONROY, DANIEL J. CUTHBERTSON, ANDRES DUARTE-ROJO, KATE HALLSWORTH, INGRID J. HICKMAN, MATTHEW R. KAPPUS, SHELLEY E. KEATING, CHRISTOPHER J. A. PUGH, YARON ROTMAN, TRACEY L. SIMON, EDUARDO VILAR-GOMEZ, VINCENT WAI-SUN WONG, KATHRYN H. SCHMITZ. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine. Medicine & Science in Sports & Exercise 2023; 55(9): 1717 doi: 10.1249/MSS.0000000000003199
|
| 119 |
Ling Ruan, Fanghui Li, Shoubang Li, Mingjun Zhang, Feng Wang, Xianli Lv, Qin Liu, Lorenzo Loffredo. Effect of Different Exercise Intensities on Hepatocyte Apoptosis in HFD‐Induced NAFLD in Rats: The Possible Role of Endoplasmic Reticulum Stress through the Regulation of the IRE1/JNK and eIF2α/CHOP Signal Pathways. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/6378568
|
| 120 |
Viniyendra Pamecha, Nilesh Sadashiv Patil, Kumaraswamy Parthasarathy, Piyush Kumar Sinha, Nihar Mohapatra, Archana Rastogi, Karthika Rudrakumar, Amar Mukund, Ashok Chaudhary, Uma Kanal. Expanding donor pool for live donor liver transplantation: utilization of donors with non-alcoholic steatohepatitis after optimization. Langenbeck's Archives of Surgery 2022; 407(4): 1575 doi: 10.1007/s00423-022-02444-5
|
| 121 |
Mehmet Sayiner, Brian Lam, Pegah Golabi, Zobair M. Younossi. Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818811508
|
| 122 |
Akshay Shetty, Wing-Kin Syn. Current treatment options for nonalcoholic fatty liver disease. Current Opinion in Gastroenterology 2019; 35(3): 168 doi: 10.1097/MOG.0000000000000528
|
| 123 |
V. T. Ivashkin, O. M. Drapkina, M. V. Maevskaya, K. L. Raikhelson, S. V. Okovityi, M. S. Zharkova, V. R. Grechishnikova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, P. O. Bogomolov, V. V. Breder, E. V. Vinnitskaya, N. I. Geyvandova, E. V. Golovanova, V. B. Grinevich, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, K. B. Kodzoeva, I. V. Kozlova, K. A. Komshilova, Yu. V. Konev, N. V. Korochanskaya, Yu. V. Kotovskaya, Yu. A. Kravchuk, I. D. Loranskaya, I. V. Maev, A. I. Martynov, S. N. Mekhtiev, E. E. Mishina, M. Yu. Nadinskaia, I. G. Nikitin, M. F. Osipenko, O. D. Ostroumova, Ch. S. Pavlov, N. V. Pogosova, V. G. Radchenko, G. E. Roytberg, R. G. Saifutdinov, A. A. Samsonov, P. V. Seliverstov, S. I. Sitkin, L. V. Tarasova, A. I. Tarzimanova, O. N. Tkacheva, E. I. Tkachenko, E. A. Troshina, S. V. Turkina, Yu. P. Uspenskiy, Yu. A. Fominykh, O. V. Khlynova, Yu. V. Tsyganova, M. Sh. Shamkhalova, O. O. Sharkhun, M. V. Shestakova. Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2025; 35(1): 94 doi: 10.22416/1382-4376-2025-35-1-94-152
|
| 124 |
Rongsheng Wang, Longlong DAI, Yanjia Zhong, Guobo Xie. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01506-9
|
| 125 |
Christian L. Horn, Anvi C. Ta, Nadege T. Gunn. Current and Emerging Treatments for Non-alcoholic Steatohepatitis. Current Hepatology Reports 2020; 19(4): 391 doi: 10.1007/s11901-020-00540-y
|
| 126 |
Sven M. Francque, Giulio Marchesini, Achim Kautz, Martine Walmsley, Rebecca Dorner, Jeffrey V. Lazarus, Shira Zelber-Sagi, Kate Hallsworth, Luca Busetto, Gema Frühbeck, Dror Dicker, Euan Woodward, Marko Korenjak, José Willemse, Gerardus H. Koek, Shlomo Vinker, Mehmet Ungan, Juan M. Mendive, Christos Lionis. Non-alcoholic fatty liver disease: A patient guideline. JHEP Reports 2021; 3(5): 100322 doi: 10.1016/j.jhepr.2021.100322
|
| 127 |
Simona Cernea, Avivit Cahn, Itamar Raz. Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes. Expert Review of Clinical Pharmacology 2017; 10(5): 535 doi: 10.1080/17512433.2017.1300059
|
| 128 |
Maximilian Huttasch, Michael Roden, Sabine Kahl. Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?. Metabolism 2024; 157: 155937 doi: 10.1016/j.metabol.2024.155937
|
| 129 |
Flavio A. Cadegiani. Dietary Interventions in Liver Disease. 2019; : 39 doi: 10.1016/B978-0-12-814466-4.00004-5
|
| 130 |
Norma Dahdah, Alba Gonzalez-Franquesa, Sara Samino, Pau Gama-Perez, Laura Herrero, José Carlos Perales, Oscar Yanes, Maria Del Mar Malagón, Pablo Miguel Garcia-Roves. Effects of Lifestyle Intervention in Tissue-Specific Lipidomic Profile of Formerly Obese Mice. International Journal of Molecular Sciences 2021; 22(7): 3694 doi: 10.3390/ijms22073694
|
| 131 |
Martin Burian, Milan Hajek, Petr Sedivy, Irena Mikova, Pavel Trunecka, Monika Dezortova. Lipid Profile and Hepatic Fat Content Measured by 1H MR Spectroscopy in Patients before and after Liver Transplantation. Metabolites 2021; 11(9): 625 doi: 10.3390/metabo11090625
|
| 132 |
David J. Hanna, Scott T. Jamieson, Christine S. Lee, Christopher A. Pluskota, Nicole J. Bressler, Peter N. Benotti, Sandeep Khurana, David D. K. Rolston, Christopher D. Still. “Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”. Obesity Science & Practice 2021; 7(5): 629 doi: 10.1002/osp4.509
|
| 133 |
María Gómez-Serrano, Emilio Camafeita, Marta Loureiro, Belén Peral, Mario Zoratti. Mitoproteomics: Tackling Mitochondrial Dysfunction in Human Disease. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/1435934
|
| 134 |
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2019; 84(1): 69 doi: 10.1016/j.rgmxen.2019.02.003
|
| 135 |
Eun-Hee Nah, Yong Jun Choi, Seon Cho, Hyeran Park, Suyoung Kim, Eunjoo Kwon, Han-Ik Cho, Jee-Fu Huang. Changes in nonalcoholic fatty liver disease and M2BPGi due to lifestyle intervention in primary healthcare. PLOS ONE 2024; 19(2): e0298151 doi: 10.1371/journal.pone.0298151
|
| 136 |
Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming-Hua Zheng, Takumi Kawaguchi, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, George Boon-bee Goh, Simone I. Strasser, Hang Dao Viet, Jia-Horng Kao, Won Kim, Seung Up Kim, Shelley E. Keating, Yusuf Yilmaz, Lubna Kamani, Chia-Chi Wang, Yasser Fouad, Zaigham Abbas, Sombat Treeprasertsuk, Kessarin Thanapirom, Mamun Al Mahtab, Undram Lkhagvaa, Oidov Baatarkhuu, Ashok Kumar Choudhury, Catherine A. M. Stedman, Abhijit Chowdhury, A Kadir Dokmeci, Fu-Sheng Wang, Han-Chieh Lin, Jee-Fu Huang, Jess Howell, Jidong Jia, Mohamed Alboraie, Stuart K. Roberts, Masato Yoneda, Hasmik Ghazinian, Aram Mirijanyan, Yuemin Nan, Cosmas Rinaldi Adithya Lesmana, Leon A. Adams, Gamal Shiha, Manoj Kumar, Necati Örmeci, Lai Wei, George Lau, Masao Omata, Shiv K. Sarin, Jacob George. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatology International 2025; 19(2): 261 doi: 10.1007/s12072-024-10774-3
|
| 137 |
Aline Mendes Gerage, Raphael Mendes Ritti‐Dias, P Babu Balagopal, Raquel Dilguerian de Oliveira Conceição, Daniel Umpierre, Raul D Santos, Gabriel Grizzo Cucato, Márcio Sommer Bittencourt. Physical activity levels and hepatic steatosis: A longitudinal follow‐up study in adults. Journal of Gastroenterology and Hepatology 2018; 33(3): 741 doi: 10.1111/jgh.13965
|
| 138 |
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, Hervé Guillou, Walter Wahli. Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease. Cells 2020; 9(7): 1638 doi: 10.3390/cells9071638
|